h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
IGIBi006-A
Registration Summary
:
A
P
E
C
DMD46-48
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
IGIBi006-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
IGIBi006-A (RRID:CVCL_C3RT)
Alternative name(s)
DMD46-48
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
19th September 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
CSIR-Institute of Genomics and Integrative Biology (IGIB)
Owner
CSIR-Institute of Genomics and Integrative Biology (IGIB)
Distributors
CSIR-Institute of Genomics and Integrative Biology (IGIB)
External Databases
Cellosaurus
CVCL_C3RT
Wikidata
Q116049568
General Information
Publications
Ahmad I et al. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene. Stem cell research. 2022 Oct;64:102927.
Kim Hyun-Jun et al. Keeping your strength up: induced pluripotent stem cell-based approaches for the treatment and investigation of skeletal muscle disorders. All Life. 2023-12-31.
Ahmad I et al. Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich's ataxia (FRDA) patients with pathogenic (GAA/TTC)n repeat expansion in first intron of the Frataxin (FXN) gene. Stem cell research. 2024 Feb;74:103289.
Ahmad I et al. Generation of two human induced pluripotent stem cell lines, IGIBi012-A and IGIBi013-A from Friedreich's ataxia (FRDA) patients with homozygous GAA repeat expansion in FXN gene. Stem cell research. 2024 Apr;76:103340.
Zahra S et al. Generation of an Induced pluripotent stem cell (iPSC) line (IGIBi011-A) from a Spinocerebellar ataxia type 12 gait dominant patient. Stem cell research. 2024 Apr;76:103319.
Josvai Mitchell et al. An engineered in vitro model of the human myotendinous junction. Acta Biomaterialia. 2024-05-00.
Ahmad I et al. Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A). Stem cell research. 2024 Jun;77:103382.
Ahmad I et al. Generation and characterization of human-derived induced pluripotent stem cell line (IGIBi010-A) from a patient with neurodegenerative disease phenotype carrying mutation in SQSTM1/p62 gene. Stem cell research. 2024 Oct;80:103520.
* Is the cell line readily obtainable for third parties?
Yes
Research use:
allowed
Clinical use:
not allowed
Commercial use:
not allowed
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.